In our robot workshop, this AI trading bot from Swing trader: Downtrend Protection v.2 (TA) was a top performer, generated 17% for PFE over the past six months.
Pfizer (PFE) is a well-known pharmaceutical company with a market capitalization of over $200 billion. Over the past six months, an AI trading robot named Swing trader: Downtrend Protection v.2 (TA) has generated a solid 17% return on PFE. This is a promising result and highlights the potential benefits of utilizing AI and machine learning algorithms to make trading decisions.
However, it is important to note that past performance is not a guarantee of future results. Even with a successful track record, it is crucial to continue monitoring the stock's momentum and any other relevant indicators to ensure that trading decisions are based on the most up-to-date information.
The Momentum Indicator is one such tool that traders can use to gauge the direction of a stock's price movement. On April 18, 2023, PFE's Momentum Indicator moved below the 0 level, which could signal a new downward trend for the stock. This is a cause for concern for traders who may want to consider selling the stock or exploring put options.
To gain a better understanding of how PFE has historically responded to this indicator turning negative, Tickeron's A.I.dvisor analyzed 81 similar instances. The results show that in 50 of these cases, the stock moved further down in the following days. This suggests that there is a 62% chance of a decline in the coming days.
It is important to note that while this information is useful for traders, it is only one piece of the puzzle. Other factors such as earnings reports, news events, and market sentiment can also influence a stock's performance. Therefore, it is crucial to conduct thorough research and analysis before making any trading decisions.
In terms of earnings results, Pfizer recently reported its first-quarter 2023 financial results. The company beat earnings estimates with adjusted earnings per share of $0.98, compared to the expected $0.96. Revenue for the quarter was $16.7 billion, which also exceeded expectations. This positive earnings report may have helped to support PFE's price in the short-term, but traders should continue to monitor the stock's momentum and other relevant indicators for any potential shifts in market sentiment.
Overall, while the AI trading robot's 17% return on PFE over the past six months is an encouraging sign, it is crucial to remain vigilant and continuously analyze relevant indicators to make informed trading decisions.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PFE advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 01, 2024. You may want to consider a long position or call options on PFE as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PFE just turned positive on May 01, 2024. Looking at past instances where PFE's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
PFE moved above its 50-day moving average on May 01, 2024 date and that indicates a change from a downward trend to an upward trend.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for PFE crossed bearishly below the 50-day moving average on April 08, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PFE broke above its upper Bollinger Band on May 01, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PFE entered a downward trend on May 03, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.763) is normal, around the industry mean (5.632). P/E Ratio (74.919) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.281) is also within normal values, averaging (3.004). Dividend Yield (0.060) settles around the average of (0.164) among similar stocks. P/S Ratio (2.674) is also within normal values, averaging (3.643).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PFE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PFE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of vaccines and injectable biologic medicines
Industry PharmaceuticalsMajor